메뉴 건너뛰기




Volumn 6, Issue 2, 2013, Pages 285-288

Treatment with ipilimumab: A case report of complete response in a metastatic malignant melanoma patient

Author keywords

Complete response; Ipilimumab; Melanoma

Indexed keywords

B RAF KINASE; DACARBAZINE; IPILIMUMAB; PEPTIDE VACCINE;

EID: 84885591238     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000351834     Document Type: Article
Times cited : (7)

References (7)
  • 1
    • 63749101977 scopus 로고    scopus 로고
    • International Agency for Research on Cancer, Lyon, IARC Press
    • International Agency for Research on Cancer: World Cancer Report 2008. Lyon, IARC Press, 2008.
    • (2008) World Cancer Report 2008
  • 3
    • 79959772576 scopus 로고    scopus 로고
    • Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
    • Robert C, Thomas L, Bondarenko I, et al: Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 2011;364:2517-2526.
    • (2011) N Engl J Med , vol.364 , pp. 2517-2526
    • Robert, C.1    Thomas, L.2    Bondarenko, I.3
  • 4
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • erratum in N Engl J Med 2010; 363: 1290
    • Hodi FS, O'Day SJ, McDermott DF, et al: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-723, erratum in N Engl J Med 2010;363:1290.
    • (2010) N Engl J Med , vol.363 , pp. 711-723
    • Hodi, F.S.1    O'Day, S.J.2    McDermott, D.F.3
  • 5
    • 79959795786 scopus 로고    scopus 로고
    • Improved survival with vemurafenib in melanoma with BRAF V600E mutation
    • Chapman PB, Hauschild A, Robert C, et al: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364:2507-2516.
    • (2011) N Engl J Med , vol.364 , pp. 2507-2516
    • Chapman, P.B.1    Hauschild, A.2    Robert, C.3
  • 7
    • 24944459890 scopus 로고    scopus 로고
    • Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
    • Attia P, Phan GQ, Maker AV, et al: Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol 2005;23:6043-6053.
    • (2005) J Clin Oncol , vol.23 , pp. 6043-6053
    • Attia, P.1    Phan, G.Q.2    Maker, A.V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.